Hypertension Trial, Recruiting NCT06450327 Sponsor: University of Campinas, Brazil Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06450327
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men and women over 35 years of age who have been diagnosed with resistant high blood pressure (blood pressure that remains high despite treatment), as defined by current medical guidelines
  • People who are able to understand, speak, and answer questions during the study
  • People who agree to take part and sign a consent form after having it clearly explained to them
  • People who have been regularly attending the UNICAMP Cardiovascular Pharmacology outpatient clinic for at least six months
  • People who have shown that they consistently follow both lifestyle recommendations and prescribed medications for their blood pressure
  • Women of childbearing age who are using a reliably effective form of contraception

Who may not be able to join:

  • People with a history or current symptoms of heart failure
  • People with certain heart conditions, including an enlarged or weakened heart muscle, heart valve problems, or disorders affecting the sac around the heart
  • People with a history of stroke or blood circulation problems in the legs, kidney disease, liver disease, smoking, autoimmune diseases, or use of illegal substances
  • People with any other health condition that the researcher believes could affect the study results or the person's safety
  • Women who are pregnant or planning to become pregnant during the study
  • People who are currently taking part in another research study
  • People with severe depression or other significant mental health conditions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +55(17)991422510

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Campinas, Brazil
Registry
ClinicalTrials.gov
Start date
27 August 2024
Est. completion
30 April 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Blood Pressure; Heart Rate; Level of TNF-α; Level of IL1β, IL-6

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov